Precision Coating, a Katahdin company, Acquired by Integer
Integer Holdings has acquired Precision Coating from Katahdin Industries, , with the transaction closing on January 7, 2025. Precision Coating is a specialized provider of surface functionality enhancement services for patient-critical products in the Medtech industry.
Since 2006, the company has expanded through five strategic acquisitions: CHN Metal Finishing (2008), Medi-Solve (2008), Boyd Coatings Research (2015), N2 Biomedical (2021), and Providence Texture (2023). The company operates from four North American locations and one in Costa Rica.
Precision Coating's key offerings include GlideLine™ fluoropolymer coatings for medical devices, MICRALOX® patented anodic coatings for reusable medical instruments, and IonGuard® ion treatment for implants. The company has achieved nearly ten-fold growth through investments in data systems, automation, materials development, and international expansion.
Integer Holdings ha acquisito Precision Coating da Katahdin Industries, con la transazione che si è conclusa il 7 gennaio 2025. Precision Coating è un fornitore specializzato di servizi di miglioramento della funzionalità superficiale per prodotti critici per i pazienti nel settore Medtech.
Dal 2006, l'azienda è cresciuta attraverso cinque acquisizioni strategiche: CHN Metal Finishing (2008), Medi-Solve (2008), Boyd Coatings Research (2015), N2 Biomedical (2021) e Providence Texture (2023). L'azienda opera da quattro sedi in Nord America e una in Costa Rica.
Le principali offerte di Precision Coating includono i rivestimenti fluoropolimerici GlideLine™ per dispositivi medici, i rivestimenti anodici brevettati MICRALOX® per strumenti medici riutilizzabili e il trattamento ionico IonGuard® per impianti. L'azienda ha raggiunto una crescita quasi dieci volte superiore grazie a investimenti in sistemi informatici, automazione, sviluppo dei materiali e espansione internazionale.
Integer Holdings ha adquirido Precision Coating de Katahdin Industries, con la transacción cerrándose el 7 de enero de 2025. Precision Coating es un proveedor especializado de servicios para la mejora de la funcionalidad superficial de productos críticos para pacientes en la industria Medtech.
Desde 2006, la empresa ha crecido a través de cinco adquisiciones estratégicas: CHN Metal Finishing (2008), Medi-Solve (2008), Boyd Coatings Research (2015), N2 Biomedical (2021) y Providence Texture (2023). La empresa opera desde cuatro ubicaciones en América del Norte y una en Costa Rica.
Las principales ofertas de Precision Coating incluyen recubrimientos de fluoropolímero GlideLine™ para dispositivos médicos, recubrimientos anódicos patentados MICRALOX® para instrumentos médicos reutilizables, y tratamiento iónico IonGuard® para implantes. La empresa ha logrado un crecimiento casi diez veces mayor a través de inversiones en sistemas de datos, automatización, desarrollo de materiales y expansión internacional.
Integer Holdings는 Katahdin Industries로부터 Precision Coating을 인수했으며, 거래는 2025년 1월 7일에 마감되었습니다. Precision Coating은 Medtech 산업에서 환자에게 중요한 제품의 표면 기능 향상 서비스 전문 제공업체입니다.
2006년 이후, 이 회사는 다섯 개의 전략적 인수를 통해 확장되었습니다: CHN Metal Finishing (2008), Medi-Solve (2008), Boyd Coatings Research (2015), N2 Biomedical (2021), 그리고 Providence Texture (2023). 이 회사는 북미의 네 개 위치와 코스타리카의 한 곳에서 운영되고 있습니다.
Precision Coating의 주요 제품에는 의료 장치를 위한 GlideLine™ 불소 폴리머 코팅, 재사용 가능한 의료 기구를 위한 MICRALOX® 특허 아노드 코팅 및 임플란트를 위한 IonGuard® 이온 처리 서비스가 포함됩니다. 이 회사는 데이터 시스템, 자동화, 소재 개발 및 국제적 확장에 대한 투자로 거의 10배 성장을 달성했습니다.
Integer Holdings a acquis Precision Coating auprès de Katahdin Industries, la transaction ayant été finalisée le 7 janvier 2025. Precision Coating est un fournisseur spécialisé dans l'amélioration de la fonctionnalité des surfaces pour des produits critiques pour les patients dans l'industrie Medtech.
Depuis 2006, l'entreprise s'est développée à travers cinq acquisitions stratégiques : CHN Metal Finishing (2008), Medi-Solve (2008), Boyd Coatings Research (2015), N2 Biomedical (2021) et Providence Texture (2023). L'entreprise opère depuis quatre sites en Amérique du Nord et un au Costa Rica.
Les principales offres de Precision Coating incluent des revêtements fluoropolymères GlideLine™ pour dispositifs médicaux, des revêtements anodiques brevetés MICRALOX® pour instruments médicaux réutilisables, et un traitement ionique IonGuard® pour implants. L'entreprise a réalisé une croissance presque multipliée par dix grâce à des investissements dans des systèmes de données, l'automatisation, le développement de matériaux et l'expansion internationale.
Integer Holdings hat Precision Coating von Katahdin Industries übernommen, wobei die Transaktion am 7. Januar 2025 abgeschlossen wurde. Precision Coating ist ein spezialisiertes Unternehmen, das Dienstleistungen zur Verbesserung der Oberflächenfunktionalität für patientenrelevante Produkte in der Medtech-Branche anbietet.
Seit 2006 hat das Unternehmen durch fünf strategische Übernahmen expandiert: CHN Metal Finishing (2008), Medi-Solve (2008), Boyd Coatings Research (2015), N2 Biomedical (2021) und Providence Texture (2023). Das Unternehmen hat vier Standorte in Nordamerika und einen in Costa Rica.
Zu den Hauptangeboten von Precision Coating gehören GlideLine™ Fluorpolymerbeschichtungen für medizinische Geräte, MICRALOX® patentierte anodische Beschichtungen für wiederverwendbare medizinische Instrumente und IonGuard® Ionenbehandlung für Implantate. Das Unternehmen hat durch Investitionen in Datensysteme, Automatisierung, Materialentwicklung und internationale Expansion ein fast zehnfaches Wachstum erzielt.
- Strategic expansion through five successful acquisitions since 2006
- Ten-fold increase in business scale
- Geographic expansion with operations across North America and Costa Rica
- Proprietary technology portfolio including GlideLine™, MICRALOX®, and IonGuard®
- None.
Insights
Integer Holdings' acquisition of Precision Coating marks a significant strategic expansion in the medical device manufacturing sector. The deal brings three key proprietary technologies: GlideLine™ (fluoropolymer coatings), MICRALOX® (anodic coatings) and IonGuard® (ion treatment), which address critical surface treatment needs in medical devices, reusable instruments and implants.
The acquisition's strategic value lies in several factors: First, Precision Coating's successful track record of integration, having absorbed five companies since 2008, demonstrates strong operational capabilities. Second, their Costa Rica facility provides Integer with expanded geographical reach and potential cost advantages. Third, the proprietary coating-as-a-service model offers recurring revenue opportunities and deeper customer relationships throughout product lifecycles.
For Integer, this acquisition strengthens their competitive position in three ways:
- Enhanced vertical integration capabilities in surface treatment technologies
- Expanded manufacturing footprint with five additional facilities
- Access to proprietary technologies that can be scaled across Integer's existing customer base
The transaction represents a continuation of Integer's strategy to build comprehensive manufacturing capabilities while adding high-margin, specialized services. The integration of Precision Coating's expertise should accelerate Integer's ability to serve the growing demand for sophisticated medical device manufacturing solutions.
Katahdin Industries, LLC is pleased to announce the sale of substantially all of the assets of Precision Coating to Integer Holdings Corporation. The transaction closed on January 7, 2025. Precision Coating provides global Medtech customers with innovative products and services to enhance the surface functionality of patient-critical products.
Since 2006, Precision Coating has built a highly specialized proprietary coatings platform in the medical technology supply chain. The portfolio build, positioning and growth trajectory was accelerated through five acquisitions including CHN Metal Finishing (2008), Medi-Solve (2008), Boyd Coatings Research (2015), a merger with N2 Biomedical (2021), and Providence Texture (2023). A nearly ten-fold increase in scale over the hold period was further facilitated by investments in data systems, automation, materials development, and greenfield expansion in
“From the very beginning, we identified precise control over surface treatment as a key feature in the medical device manufacturing process,” commented Tim Cabot, Chairman of Katahdin. “We also saw a gap in the market to address unique coating-as-a-service needs for medical device customers and to position the company to become a fully capable contract manufacturing services provider for the full life cycle of each product we work on. Over time our market focus has also allowed us to expand and enhance our specialized, high-value, and innovative application solutions, including GlideLine™, our proprietary fluoropolymer coatings for medical devices; MICRALOX®, our patented anodic coatings for re-usable medical instruments; and IonGuard®, our proprietary ion treatment for implants.”
Bill Ellerkamp, President of Precision Coating, added, “We are very excited about the acquisition of Precision Coating by Integer. We are proud of the strong and defensible position we’ve built in the proprietary coatings segment of the Medtech industry and the exceptional company culture we’ve created. Integer is uniquely positioned to capitalize on the strengths of our technologies and our respective cultures are well aligned. We are confident in the future of Precision Coating as part of Integer.”
Piper Sandler & Co. served as exclusive financial advisor to Katahdin and Ruberto,
About Katahdin
Katahdin Industries, LLC is a closely held investment corporation with both individual and institutional ownership. Following Katahdin’s 2021 merger with N2 Biomedical, Ampersand Capital Partners became a minority shareholder and provided strategic guidance cultivated from a deep history of investing in medical contract design and manufacturing organizations. Tim Cabot and Bob DeAngelis led the original acquisition and company build out through 2018 when Bill Ellerkamp became President of Precision Coating. Additional information about Precision Coating is available at www.precisioncoating.com.
About Ampersand Capital Partners
Founded in 1988, Ampersand Capital Partners is a middle market private equity firm with
About Integer®
Integer Holdings Corporation (NYSE: ITGR) is one of the largest medical device contract development and manufacturing organizations (CDMO) in the world, serving the cardiac rhythm management, neuromodulation, and cardio and vascular markets. As a strategic partner of choice to medical device companies and OEMs, the Company is committed to enhancing the lives of patients worldwide by providing innovative, high-quality products and solutions. The Company's brands include Greatbatch Medical® and Lake Region Medical®. Additional information is available at www.integer.net
View source version on businesswire.com: https://www.businesswire.com/news/home/20250204761444/en/
Bill Ellerkamp, President of Precision Coating
978.562.7561
Source: Precision Coating
FAQ
When did Integer Holdings acquire Precision Coating (ITGR)?
What are the main proprietary technologies acquired by ITGR through Precision Coating?
How many facilities does ITGR gain through the Precision Coating acquisition?
What acquisitions did Precision Coating complete before being acquired by ITGR?
